📢 New EORTC–ESTRO OligoCare publication. Published in @TheLancetOncol, this third OligoCare consensus paper recommends primary endpoints for trials of MDT in oligometastatic cancer, supporting patient‑centred research. Read more: www.eortc.org/publications/ #ClinicalTrials #CancerResearch

1 likes 0 replies